| P2093 | author name string | Kay Brune | |
| | Mehmet Ates | |
| | Catherine Ledent | |
| | May Hamza | |
| | Hans Gühring | |
| | Marina Sergejeva | |
| | Carolin E Kotalla | |
| P2860 | cites work | Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase | Q24555807 |
| | Cannabinoid receptors and pain | Q28143655 |
| | Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors | Q28292914 |
| | Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice | Q28343324 |
| | Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries | Q28362103 |
| | Characterization of EP receptor subtypes responsible for prostaglandin E2-induced pain responses by use of EP1 and EP3 receptor knockout mice | Q28365869 |
| | International Union of Pharmacology. XXVII. Classification of cannabinoid receptors | Q29616832 |
| | Ethical guidelines for investigations of experimental pain in conscious animals | Q29617510 |
| | A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia | Q29620385 |
| | The anandamide transport inhibitor AM404 activates vanilloid receptors. | Q31384563 |
| | Suppressed injury-induced rise in spinal prostaglandin E2 production and reduced early thermal hyperalgesia in iNOS-deficient mice. | Q31432554 |
| | Pain modulation by release of the endogenous cannabinoid anandamide | Q33421146 |
| | Biosynthesis and inactivation of endocannabinoids: relevance to their proposed role as neuromodulators | Q33720127 |
| | The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors | Q33940288 |
| | Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets | Q33946795 |
| | Nitric oxide synthase 2 and cyclooxygenase 2 interactions in inflammation | Q34242689 |
| | Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance | Q34673072 |
| | Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids | Q34792988 |
| | The formalin test: an evaluation of the method | Q35555523 |
| | High times for cannabis research | Q35975796 |
| | Flurbiprofen enantiomers inhibit inducible nitric oxide synthase expression in RAW 264.7 macrophages | Q40798834 |
| | Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system | Q40998257 |
| | Repression of inducible nitric oxide synthase and cyclooxygenase-2 by prostaglandin E2 and other cyclic AMP stimulants in J774 macrophages | Q41126924 |
| | Prostaglandin E2 regulates inducible nitric oxide synthase in the murine macrophage cell line J774. | Q41378525 |
| | A fluorometric assay for the measurement of nitrite in biological samples. | Q41526007 |
| | Modulation of the induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774 | Q41597746 |
| | Use and benefits of nonsteroidal anti-inflammatory drugs | Q41757682 |
| | Aspirin-like drugs may block pain independently of prostaglandin synthesis inhibition | Q41761956 |
| | Regulation of prostaglandin production by nitric oxide; an in vivo analysis | Q42013248 |
| | The effect of morphine on formalin-evoked behaviour and spinal release of excitatory amino acids and prostaglandin E2 using microdialysis in conscious rats | Q42369976 |
| | Differences in the pharmacological properties of rat and chicken brain fatty acid amidohydrolase | Q43264516 |
| | Chronic intrathecal cannulation enhances nociceptive responses in rats | Q43505670 |
| | Role of nitric oxide in zymosan induced paw inflammation and thermal hyperalgesia | Q43566674 |
| | Indomethacin prevents the induction of inducible nitric oxide synthase in murine peritoneal macrophages and decreases their nitric oxide production | Q43567838 |
| | Release of glutamate, nitric oxide and prostaglandin E2 and metabolic activity in the spinal cord of rats following peripheral nociceptive stimulation | Q43588895 |
| | The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats | Q43674677 |
| | Small part of cannabis puzzle solved by animal studies | Q43702833 |
| | HU-210 shows higher efficacy and potency than morphine after intrathecal administration in the mouse formalin test | Q43791861 |
| | Characterization of delta9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats | Q45111719 |
| | Effects of cyclooxygenase products of arachidonic acid metabolism on cutaneous nociceptive threshold in the rat. | Q46121771 |
| | Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats | Q46176636 |
| | Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition | Q46223466 |
| | Antihyperalgesic effects of spinal cannabinoids | Q47625816 |
| | Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice | Q47994629 |
| | Anandamide hydrolysis by human cells in culture and brain | Q48346766 |
| | 123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors | Q48966515 |
| | Estimation of the in vivo effect of cyclooxygenase inhibitors on prostaglandin E2 levels in mouse brain | Q49021818 |
| | Intrathecal administration of a new nitric oxide donor, NOC-18, produces acute thermal hyperalgesia in the rat. | Q50525709 |
| | A new nitric oxide donor, NOC-18, exhibits a nociceptive effect in the rat formalin model. | Q50535875 |
| | Major roles of prostanoid receptors IP and EP3 in endotoxin-induced enhancement of pain perception11Abbreviations:, prostaglandin E receptor subtype 1; IP, prostaglandin I receptor; LPS, lipopolysaccharide; and WT, wild-type mice | Q57613937 |
| | Anandamide Uptake by Human Endothelial Cells and Its Regulation by Nitric Oxide | Q60690623 |
| | Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients | Q66906547 |
| | Effects of acetylsalicylic acid and indomethacin on single groups III and IV sensory units from acutely inflamed joints | Q68741129 |
| | Intrathecal morphine in mice: a new technique | Q71852099 |
| | New NO‐Donors with Antithrombotic and Vasodilating Activities, X: Antiplatelet and Antithrombotic Effects of 3‐Methylsydnone‐5‐nitrosimine (RE 2047) in Combination with ASA, Pentoxifylline, and Ticlopidine | Q72107842 |
| | Allodynia evoked by intrathecal administration of prostaglandin E2 to conscious mice | Q72692259 |
| | Biosynthesis and turnover of anandamide and other N-acylethanolamines in peritoneal macrophages | Q73047443 |
| | Reversal of dopamine D(2) receptor responses by an anandamide transport inhibitor | Q73704501 |
| P433 | issue | 2-3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endocannabinoids | Q10483908 |
| P304 | page(s) | 153-163 | |
| P577 | publication date | 2002-11-01 | |
| P1433 | published in | European Journal of Pharmacology | Q1376712 |
| P1476 | title | A role for endocannabinoids in indomethacin-induced spinal antinociception | |
| P478 | volume | 454 | |